AtlasClear grants stock and options to president
AtlasClear Holdings, Inc. reported that President and director Craig Ridenhour received equity compensation awards on July 14, 2026.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
AtlasClear Holdings, Inc. reported that President and director Craig Ridenhour received equity compensation awards on July 14, 2026. He was granted 700,000 shares of restricted stock that vested immediately and 286,842 restricted shares vesting June 30, 2027, plus stock options for 40,000 and 731,030 shares at a $0.1800 exercise price, expiring in 2030 and 2031.
Insider Trade Summary
Grant/Award: 1,757,872 shares
Grant/Award
4 txns
Insider
Ridenhour Craig
Role
President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 40,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 731,030 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 700,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F2 | 286,842 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 771,030 contracts (Direct);
Common Stock — 986,842 shares (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 771,030 contracts (Direct);
Common Stock, 0 to 986,842 shares (Direct)
Footnotes (2)
- F1. Represents shares of restricted stock granted to the Reporting Person pursuant to the terms of an Employment Agreement between the Reporting Person and the Issuer (the "Employment Agreement"), which shares are immediately vested in full.
- F2. Represents shares of restricted stock granted to the Reporting Person pursuant to the terms of the Employment Agreement, which shares vest in full on June 30, 2027 (subject to continued employment through such date).
Key Figures
Restricted stock grant (immediate): 700,000 shares
Restricted stock grant (vesting 2027): 286,842 shares
Stock options grant (2030 expiry): 40,000 options at $0.1800 per share
+1 more
4 metrics
Restricted stock grant (immediate)
700,000 shares
Granted to President Craig Ridenhour; immediately vested in full under Employment Agreement
Restricted stock grant (vesting 2027)
286,842 shares
Vests in full on June 30, 2027, subject to continued employment
Stock options grant (2030 expiry)
40,000 options at $0.1800 per share
Stock Option (right to buy) with $0.1800 exercise price; expiration date January 26, 2030
Stock options grant (2031 expiry)
731,030 options at $0.1800 per share
Stock Option (right to buy) with $0.1800 exercise price; expiration date June 30, 2031
Key Terms
Stock Option (right to buy), restricted stock, Employment Agreement, exercise price
4 terms
Stock Option (right to buy) financial
"Security title reported as Stock Option (right to buy) with $0.1800 exercise price"
restricted stock financial
"Footnotes describe shares of restricted stock granted under an Employment Agreement"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Employment Agreement financial
"Restricted stock was granted pursuant to the terms of an Employment Agreement"
exercise price financial
"Conversion or exercise price for the options is $0.1800 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AtlasClear (ATCH) president Craig Ridenhour receive on July 14, 2026?
Craig Ridenhour received 700,000 immediately vested restricted shares, 286,842 additional restricted shares, and stock options for 40,000 and 731,030 shares at a $0.1800 exercise price as part of his equity compensation package.
How do the restricted stock grants for AtlasClear (ATCH) president Craig Ridenhour vest?
Ridenhour received 700,000 restricted shares that are immediately vested in full. A separate grant of 286,842 restricted shares vests in full on June 30, 2027, subject to his continued employment through that date under his Employment Agreement.
What are the key terms of Craig Ridenhour’s stock options in AtlasClear (ATCH)?
Ridenhour was granted stock options covering 40,000 and 731,030 shares of common stock, each with an exercise price of $0.1800 per share. The options expire on January 26, 2030 and June 30, 2031, respectively.
Are the AtlasClear (ATCH) transactions for Craig Ridenhour open-market trades?
No. The reported transactions are grants of restricted stock and stock options at a $0.0000 transaction price per share. They represent equity compensation awards, not discretionary open‑market purchases or sales of AtlasClear Holdings common stock.
What role does Craig Ridenhour hold at AtlasClear (ATCH) in this Form 4 report?
Craig Ridenhour is identified as both a director and an officer, serving as President of AtlasClear Holdings, Inc. The reported restricted stock and option awards were granted to him in connection with his employment arrangement.
How are the AtlasClear (ATCH) restricted stock grants linked to Craig Ridenhour’s Employment Agreement?
Footnotes explain that both restricted stock grants were made pursuant to an Employment Agreement. The 700,000 shares vest immediately under that agreement, while the 286,842 shares vest in full on June 30, 2027, contingent on continued employment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
